Enhancement of cytotoxic T lymphocyte activity by dendritic cells loaded with Tat-protein transduction domain-fused hepatitis B virus core antigen

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 12, 2008, Pages 996-1004

  Chen, Xiaohua ^a   Yu, Yongsheng ^a   Pan, Qingchun ^a   Tang, Zhenghao ^a   Han, Jinchao ^a   Zang, Guoqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte; Dendritic cell; HBV core antigen; Tat PTD

Indexed keywords

HEPATITIS B CORE ANTIGEN; INTERLEUKIN 12; PRIMER DNA; TRANSACTIVATOR PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE; MOUSE; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; CHROMATOGRAPHY, AFFINITY; DENDRITIC CELLS; DNA PRIMERS; GENE PRODUCTS, TAT; HEPATITIS B CORE ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 57849168395     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00487.x     Document Type: Article

References (22)

1. Seeger C, Mason WS., Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64 : 51 68
2. Yang SH, Lee CG, Park SH., Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study. Gene Ther 2006, 13 : 1110 1117
3. Penna A, Chisari FV, Bertoletti A, Missale G, Missale G, Fowler P, Giuberti T et al., Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991, 174 : 1565 1570
4. Löhr HF, Krug S, Herr W, Weyer S, Schlaak J, Wölfel T, Gerken G et al., Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B. Liver 1998, 18 : 405 413
5. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, Knop J et al., Pro-infammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997, 27 : 3135 3142
6. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV., Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 1995, 96 : 1527 1534
7. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV., Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a non-cytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 1994, 91 : 3764 3768
8. + T-cell responses in HLA-A2.1/Kb transgenic mice. Immunology 2007, 121 : 105 112
9. Kim DT, Mitchell DJ, Brockstedt DG, Fong L, Nolan GP, Fathman CG, Engleman EG et al., Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J Immunol 1997, 159 : 1666 1668
10. + T cells. J Immunol 2003, 171 : 5198 5207
11. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF., Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 2001, 61 : 474 477
12. Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K, Bresolin N et al., Intracellular delivery of a TateGFP fusion protein into muscle cells. Mol Ther 2001, 3 : 310 318
13. Bergamo P, Maurano F, D'Arienzo R, David C, Rossi M., Association between activation of phase 2 enzymes and down-regulation of dendritic cell maturation by c9,t11-conjugated linoleic acid. Immunol Lett 2008, 117 : 181 190
14. Huang Y, Chen Z, Zhou C, Yao H, Li M, Xu C., The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha. Int Immunopharmacol 2004, 4 : 539 546
15. Vives E, Brodin P, Lebleu B., A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997, 272 : 16010 16017
16. Dietz GP, Bahr M., Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 2004, 27 : 85 131
17. Dietz GP, Kilic E, Bahr M., Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol Cell Neurosci 2002, 21 : 29 37
18. Tolia NH, Joshua-Tor L., Strategies for protein coexpression in Escherichia coli. Nat Methods 2006, 3 : 55 64
19. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M et al., Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD41 T cells. J Immunol 1995, 154 : 5071 5079
20. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kämpgen E, Romani N et al., High level IL-12 production by murine dendritic cells up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J Exp Med 1996, 184 : 741 746
21. + effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor. J Immunol 2000, 164 : 916 925
22. Tsuji T, Chamoto K, Funamoto H, Kosaka A, Matsuzaki J, Abe H, Fujio K et al., Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy. Cancer Sci 2003, 94 : 924 928